Skip to content
10-Q

Quarterly Report

CHINA HEALTH INDUSTRIES HOLDINGS, INC.

0001213900-24-055976

← back to feed
Filed
Jun 26, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Jun 26, 2024 65.54M sh
Shares Diluted Q3 2024 · Mar 31, 2024 65.54M sh
Shares Diluted Q3 2024 · Mar 31, 2024 65.54M sh
Shares Diluted Q3 2024 · Mar 31, 2023 65.54M sh
Shares Diluted Q3 2024 · Mar 31, 2023 65.54M sh
Operating Cash Flow Q3 2024 · Mar 31, 2024 −$31.69K
Operating Cash Flow Q3 2024 · Mar 31, 2023 $489.8K
Short Term Debt Q3 2024 · Mar 31, 2024 $34.63K
Cash And Equivalents Q3 2024 · Mar 31, 2024 $18.1K
Cash And Equivalents Q3 2024 · Jun 30, 2023 $47.25K
Stockholders Equity Q3 2024 · Mar 31, 2024 −$2.4M
Stockholders Equity Q3 2024 · Dec 31, 2023 −$2.29M
Stockholders Equity Q3 2024 · Jun 30, 2023 $39.11M
Stockholders Equity Q3 2024 · Mar 31, 2023 $41.92M
Stockholders Equity Q3 2024 · Dec 31, 2022 $42.03M
Stockholders Equity Q3 2024 · Jun 30, 2022 $42.8M
Current Liabilities Q3 2024 · Mar 31, 2024 $6.53M
Current Liabilities Q3 2024 · Jun 30, 2023 $5.97M
Current Assets Q3 2024 · Mar 31, 2024 $248.29K
Current Assets Q3 2024 · Jun 30, 2023 $40.97M
Total Assets Q3 2024 · Mar 31, 2024 $4.13M
Total Assets Q3 2024 · Jun 30, 2023 $45.08M
Eps Diluted Q3 2024 · Mar 31, 2024 −$0.00
Eps Diluted Q3 2024 · Mar 31, 2024 −$0.01
Eps Diluted Q3 2024 · Mar 31, 2023 −$0.00
Eps Diluted Q3 2024 · Mar 31, 2023 $0.00
Eps Basic Q3 2024 · Mar 31, 2024 −$0.00
Eps Basic Q3 2024 · Mar 31, 2024 −$0.01
Eps Basic Q3 2024 · Mar 31, 2023 −$0.00
Eps Basic Q3 2024 · Mar 31, 2023 $0.00
Sga Expense Q3 2024 · Mar 31, 2024 $72.56K
Sga Expense Q3 2024 · Mar 31, 2024 $524.62K
Sga Expense Q3 2024 · Mar 31, 2023 $152.63K
Sga Expense Q3 2024 · Mar 31, 2023 $710.95K
Net Income Q3 2024 · Mar 31, 2024 −$142.75K
Net Income Q3 2024 · Mar 31, 2024 −$770.66K
Net Income Q3 2024 · Mar 31, 2023 −$290.29K
Net Income Q3 2024 · Mar 31, 2023 $182.57K
Operating Income Q3 2024 · Mar 31, 2024 −$142.26K
Operating Income Q3 2024 · Mar 31, 2024 −$771.77K
Operating Income Q3 2024 · Mar 31, 2023 −$329.47K
Operating Income Q3 2024 · Mar 31, 2023 −$1.23M
Cost Of Revenue Q3 2024 · Mar 31, 2024 $87
Cost Of Revenue Q3 2024 · Mar 31, 2024 $38.43K
Cost Of Revenue Q3 2024 · Mar 31, 2023 $19.08K
Cost Of Revenue Q3 2024 · Mar 31, 2023 $48.73K
Revenue Q3 2024 · Mar 31, 2024 $87
Revenue Q3 2024 · Mar 31, 2024 $38.43K
Revenue Q3 2024 · Mar 31, 2023 $21.42K
Revenue Q3 2024 · Mar 31, 2023 $54.07K
Gross Profit Q3 2024 · Mar 31, 2023 $2.33K
Gross Profit Q3 2024 · Mar 31, 2023 $5.34K